The management of thrombocytosis
暂无分享,去创建一个
[1] C. Harrison,et al. Essential thrombocythaemia , 2015, Hematology.
[2] B. Risberg,et al. Splenic platelet kinetics and platelet production after major reconstructive vascular surgery. , 2009, Acta medica Scandinavica.
[3] J. Kutti,et al. Platelet survival and platelet production in acute myocardial infarction. , 2009, Acta medica Scandinavica.
[4] B. Ridell,et al. Megakaryocyte quantifications in relation to thrombokinetics in primary thrombocythaemia and allied diseases. , 2009, Scandinavian journal of haematology.
[5] L. Schutz,et al. Platelet function abnormalities in the myeloproliferative disorders. , 2009, Scandinavian journal of haematology.
[6] J. Westin,et al. The relation of thrombokinetics to bone marrow megakaryocytes and to the size of the spleen in polycythaemia vera. , 2009, Scandinavian journal of haematology.
[7] J. Westin,et al. The relationship between splenic platelet pool and spleen size. , 2009, Scandinavian journal of haematology.
[8] A. F. Abrahamsen. Effects of an enlarged splenic platelet pool in Hodgkin's disease. , 2009, Scandinavian journal of haematology.
[9] P. Lundin,et al. The significance of bone marrow morphology for the diagnosis of polycythaemia vera. , 2009, Scandinavian journal of haematology.
[10] J. Kutti,et al. Platelet survival in man. , 2009, Scandinavian journal of haematology.
[11] E. Pogliani,et al. Effect of nimergoline (F.I. 6714) on human platelet aggregation in vitro. , 2009, Acta medica Scandinavica. Supplementum.
[12] S. Lewis,et al. The splenomegaly of myeloproliferative and lymphoproliferative disorders: Splenic cellularity and vascularity , 1989, European journal of haematology.
[13] G. Tobelem. 9 Essential thrombocythaemia , 1989 .
[14] T. Hovig. 1 Megakaryocyte and platelet morphology , 1989 .
[15] F. Mandelli,et al. Interferon alpha‐2b as treatment for Philadelphia‐negative chronic myeloproliferative disorders with excessive thrombocytosis , 1989, British journal of haematology.
[16] A. Guarini,et al. In vivo and in vitro inhibitory effect of α‐interferon on megakaryocyte colony growth in essential thrombocythaemia , 1989, British journal of haematology.
[17] A. Chetrit,et al. Platelet parameters and aggregation in essential and reactive thrombocytosis. , 1988, American journal of clinical pathology.
[18] A. Wåhlin,et al. Management of polycythaemia vera, essential thrombocythaemia and myelofibrosis with hydroxyurea * , 1988, European journal of haematology.
[19] P. Noris,et al. Platelet aggregation in platelet rich plasma and whole blood in 18 patients affected by idiopathic myelofibrosis * , 1988, European journal of haematology.
[20] A. Mehta,et al. ALPHA-INTERFERON THERAPY FOR ESSENTIAL THROMBOCYTHAEMIA , 1988, The Lancet.
[21] H. Wadenvik,et al. The spleen and pooling of blood cells , 1988, European journal of haematology.
[22] C. Thompson,et al. The pathophysiology and clinical relevance of platelet heterogeneity. , 1988, Blood.
[23] R. Hehlmann,et al. Essential thrombocythemia. Clinical characteristics and course of 61 cases , 1988, Cancer.
[24] Knight Rc,et al. Anagrelide: a new drug for treating thrombocytosis. , 1988, The New England journal of medicine.
[25] J. Adamson. Wither the platelet? , 1988, The New England journal of medicine.
[26] T. Pearson,et al. Use of splenic volume estimation to distinguish primary thrombocythaemia from reactive thrombocytosis , 1988, European journal of haematology.
[27] R. Baker,et al. Platelet function in myeloproliferative disorders: Characterization and sequential studies show multiple platelet abnormalities, and change with time , 1988, European journal of haematology.
[28] P. White,et al. Clinical presentation and natural history of patients with essential thrombocythemia and the Philadelphia chromosome , 1988, American journal of hematology.
[29] H. Wadenvik,et al. The effect of an adrenaline infusion on the splenic blood flow and intrasplenic platelet kinetics , 1987, British journal of haematology.
[30] H. Wadenvik,et al. Splenic blood flow and intrasplenic platelet kinetics in relation to spleen volume , 1987, British journal of haematology.
[31] H. Wadenvik,et al. The effect of an isoprenaline infusion on the splenic blood flow and intrasplenic platelet kinetics , 1987, European journal of haematology.
[32] W. Bezwoda,et al. Reactive thrombocytosis in pulmonary tuberculosis. , 1987, Journal of clinical pathology.
[33] T. Reichert,et al. Differentiation between essential thrombocythemia and polycythemia vera with marked thrombocytosis , 1987, American journal of hematology.
[34] T. Pearson,et al. 4 Polycythaemia and thrombocythaemia in the elderly , 1987 .
[35] H. Wadenvik,et al. In vitro and in vivo behavior of 111In‐labelled platelets: An experimental study of healthy male volunteers , 1987, European journal of haematology.
[36] R. Berger,et al. Essential thrombocythemias. Clinical evolutionary and biological data , 1986, Cancer.
[37] J. Laszlo,et al. Essential thrombocythemia: an interim report from the Polycythemia Vera Study Group. , 1986, Seminars in hematology.
[38] J. Goldberg,et al. Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols. , 1986, Seminars in hematology.
[39] J. Steketee,et al. Erythromelalgia caused by platelet-mediated arteriolar inflammation and thrombosis in thrombocythemia. , 1985, Annals of internal medicine.
[40] S. Lewis,et al. The interpretation of platelet kinetic studies for the identification of sites of abnormal platelet destruction , 1984, British journal of haematology.
[41] A. Schafer. Bleeding and thrombosis in the myeloproliferative disorders. , 1984, Blood.
[42] M. Welch,et al. Radiolabeling of platelets. , 1984, Seminars in nuclear medicine.
[43] Peters Am,et al. Platelet Kinetics with Indium-111 Platelets: Comparison with Chromium-51 Platelets , 1983, Seminars in thrombosis and hemostasis.
[44] S. Murphy. Thrombocytosis and thrombocythaemia. , 1983, Clinics in haematology.
[45] A. Peters,et al. Factors controlling the intrasplenic transit of platelets , 1982, European journal of clinical investigation.
[46] S. Lewis,et al. Use of lllIndium‐labelled Platelets to Measure Spleen Function , 1980 .
[47] M. G. Lötter,et al. Kinetics, Distribution and Sites of Destruction of 111Indium‐labelled Human Platelets , 1980, British journal of haematology.
[48] B. Bengtsson,et al. Thrombokinetics in giant cell arteritis, with special reference to corticosteroid therapy. , 1979, Annals of the rheumatic diseases.
[49] P. Insel,et al. Platelet function in essential thrombocythemia. Decreased epinephrine responsiveness associated with a deficiency of platelet alpha-adrenergic receptors. , 1978, The New England journal of medicine.
[50] B. Boughton,et al. Chronic Myeloproliferative Disorders: Improved Platelet Aggregation following Venesection , 1978, British journal of haematology.
[51] M. Boxer,et al. Thromboembolic risk of postsplenectomy thrombocytosis. , 1978, Archives of surgery.
[52] O. Selroos,et al. Thrombocytosis in rheumatoid arthritis. Recurrent arterial thromboembolism and death. , 1977, Annals of the rheumatic diseases.
[53] M. Welch,et al. Indium-LLL labeled platelets: studies on preparation and evaluation of in vitro and in vivo functions. , 1976, Thrombosis research.
[54] R. Hutchinson,et al. Thrombocytosis in rheumatoid arthritis. , 1976, Annals of the rheumatic diseases.
[55] S. Geller,et al. The bone marrow in polycythemia vera. , 1975, Seminars in hematology.
[56] J. Kutti,et al. Platelets in the myeloproliferative syndrome. , 1975, Clinics in haematology.
[57] B Swolin,et al. The relation of thrombokinetics to bone marrow megakaryocytes in idiopathic thrombocytopenic purpura (ITP). , 1975, Blood.
[58] A. Haut,et al. Thrombocytosis: platelet kinetics in neoplasia. , 1974, The Journal of laboratory and clinical medicine.
[59] V. Devita,et al. Thrombocytosis in chronic granulocytic leukemia: incidence and clinical significance. , 1974, Blood.
[60] R. Pierre,et al. Dysplastic platelets and circulating megakaryocytes in chronic myeloproliferative diseases. I. The platelets: ultrastructure and peroxidase reaction. , 1974, Blood.
[61] L. Wasserman,et al. Abnormalities of platelet function in patients with polycythemia vera. , 1973, Cancer research.
[62] The Platelets , 1973 .
[63] M. Block,et al. Bone marrow sections in the differential diagnosis of polycythemia. , 1972, Archives of pathology.
[64] L. Harker,et al. Platelet and fibrinogen consumption in man. , 1972, The New England journal of medicine.
[65] S. Zucker,et al. Classification of thrombocytosis based on platelet function tests: correlation with hemorrhagic and thrombotic complications. , 1972, The Journal of laboratory and clinical medicine.
[66] J. Neemeh,et al. Quantitation of platelet aggregation in myeloproliferative disorders. , 1972, American journal of clinical pathology.
[67] L. Harker. Thrombokinetics in Idiopathic Thrombocytopenic Purpura * , 1970, British journal of haematology.
[68] T. Spaet,et al. Defective platelets in essential thrombocythemia. , 1969, Archives of internal medicine.
[69] L. Harker,et al. Thrombokinetics in man. , 1969, The Journal of clinical investigation.
[70] R. Aster. Pooling of platelets in the spleen: role in the pathogenesis of "hypersplenic" thrombocytopenia. , 1966, The Journal of clinical investigation.
[71] R. Aster,et al. PLATELET SEQUESTRATION IN MAN. I. METHODS. , 1964, The Journal of clinical investigation.
[72] J. Zajicek,et al. Microplanimetric studies on megakaryocytes in chronic granulocytic leukaemia and polycythaemia vera. , 1961, Acta haematologica.
[73] F. Gardner,et al. Survival of blood platelets labeled with chromium. , 1958, The Journal of clinical investigation.
[74] J. H. Wright. The Origin and Nature of the Blood Plates , 1906 .
[75] Philip R. Cohen,et al. Erythromelalgia and myeloproliferative disorders. , 1989, Archives of internal medicine.
[76] T. Hovig. Megakaryocyte and platelet morphology. , 1989, Bailliere's clinical haematology.
[77] M. Myers. Spleen imaging. , 1983, Clinics in haematology.
[78] G. Faguet,et al. Evidence that essential thrombocythemia is a clonal disorder with origin in a multipotent stem cell. , 1981, Blood.
[79] F. Gardner,et al. Microscopic platelet size and morphology in various hematologic disorders. , 1978, Blood.
[80] J. Kutti,et al. Platelet Survival and Platelet Production in Systemic Lupus Erythematosus (SLE) , 1975, Thrombosis and Haemostasis.
[81] M. Baldini,et al. Idiopathic thrombocytopenic purpura and the ITP syndrome. , 1972, The Medical clinics of North America.
[82] J. Westin,et al. Spleen size in polycythemia. A clinical and scintigraphic study. , 1972, Acta medica Scandinavica.
[83] M. Kotilainen. Platelet kinetics in normal subjects and in haematological disorders; with special reference to thrombocytopenia and to the role of the spleen. , 1969, Scandinavian journal of haematology. Supplementum.
[84] Abrahamsen Af. Platelet survival studies in man. With special reference to thrombosis and atherosclerosis. , 1968 .
[85] A. F. Abrahamsen. Platelet survival studies in man. With special reference to thrombosis and atherosclerosis. , 1968, Scandinavian journal of haematology. Supplementum.
[86] R. Penny,et al. The splenic platelet pool. , 1966, Blood.
[87] A. Videbaek. Polycythaemia vera. Course and prognosis. , 1950, Acta medica Scandinavica.